EUR/USD 1.13978
-0.218%
Gold 3973.16
-1.081%
Oil 70.277
0.003%
USD/JPY 162.177
0.151%
GBP/USD 1.32326
-0.187%
GBP/JPY 214.609
-0.027%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On June 30th, Goldman Sachs Timothy Moe and John Kwon pointed out that a 1% increase in the combined weighting of Samsung and SK Hynix in the South Korean stock index could lead to foreign investors withdrawing approximately $2 billion from the South Korean market, as the US Investment Company Act requires portfolios to meet diversification thresholds. Goldman Sachs also stated that a large influx of funds into leveraged ETFs, coupled with increased options trading and margin retail trading, has created a structural environment where daily price volatility far exceeds what corporate fundamentals can support. South Koreas asset management growth since last year has primarily stemmed from investment returns rather than new capital inflows. As valuations climb, institutional investors mechanical exposure to market volatility is also increasing—often related to hedging strategies. This means that even a mild market correction could trigger a cascade of forced selling.Hong Kong-listed pharmaceutical company Jieankang-B (02617.HK) saw a significant pullback today, falling more than 10% intraday, after surging nearly 40% yesterday.June 30th - It was learned today that, to further promote the inheritance and innovative development of traditional Chinese medicine (TCM), four national standards in the field of TCM, proposed and managed by the State Administration of Traditional Chinese Medicine and approved by the State Administration for Market Regulation (National Standardization Administration), namely, *Basic Theory and Terminology of Traditional Chinese Medicine*, *Diagnostic Vocabulary of Traditional Chinese Medicine Part 1: Tongue Appearance*, *Diagnostic Vocabulary of Traditional Chinese Medicine Part 2: Pulse Appearance*, and *Quality Control Standards for Clinical Research in Traditional Chinese Medicine*, will be implemented from July 1st. The *Quality Control Standards for Clinical Research in Traditional Chinese Medicine* is the first national standard in the field of TCM clinical research, establishing four main contents around the entire clinical research process. The four standards released this time each have their own focus, concentrating on three key areas: basic theory, diagnostic vocabulary, and clinical research. They take into account both the inheritance of traditional connotations and the needs of modern application, addressing long-standing industry problems such as inconsistent TCM terminology and an imperfect quality control system for clinical research, and are conducive to improving the standardization, scientification, and internationalization of the TCM industry.On June 30th, Maybank analysts pointed out that the yens break above the 162 level against the US dollar has triggered intervention risks, as this level is considered a critical threshold for potential official action. In their report, they wrote that it is currently unclear whether intervention is imminent or underway, but officials have consistently issued warning statements. Maybank is closely monitoring the potential for sharp exchange rate fluctuations accompanying intervention, noting that Japan has ample "ammunition" in the form of deposits and securities, far exceeding the scale of the previous intervention which cost approximately US$74 billion. "Currently, we are watching whether the currency pair can hold the 162.00 level in the short term; if it breaks through, the next resistance level is at 164.00." Maybank set support levels at 158.00 and 155.00.Local media reported that a fire broke out at the Hardia oil refinery in India, the cause of which is still unknown.

AUD/NZD has not changed from 1.1230 despite RBA Lowe's testimony

Daniel Rogers

Sep 16, 2022 14:54

截屏2022-09-16 上午10.02.37.png 

 

There has been no movement in the AUD/NZD pair throughout the Tokyo session despite evidence from Philip Lowe, governor of the Reserve Bank of Australia (RBA). Despite a recent dip, the asset is trading within a narrow range of 1.1220 to 1.1232. Tuesday's attempt to break through 1.1258 was unsuccessful, and the asset subsequently fell. The likelihood of a negative reversal has grown due to the presence of strong selling pressure at current elevated levels.

 

As Lowe testified, he plans to do so, inflationary pressures will be reduced. The RBA is not as eager as some other central banks would be to attain price stability if it meant sacrificing economic development.

 

Although the central bank is not following a set course, market participants should keep in mind that the RBA has pegged an objective for the Official Cash Rate (OCR) of 3.85%. RBA Despite his conviction that "labor cost rise is consistent with inflation returning to goal," Lowe has painted a bleak outlook for the economy.

 

Earlier, the Aussie bulls were under pressure after weaker-than-expected job data was released in Australia. Statistics on Employment Change fell short, coming in at 33.5k instead of the expected 35k. The economy reported 40,900 job losses in July. The increase in the unemployment rate was also quite large, coming in at 3.5% compared to 3.4% forecasted and 3.4% reported previously.

 

As for New Zealand, the bullish Business NZ PMI data released early in the Tokyo session has not caused a notable reaction from kiwi buyers. Numbers for the economy were better than expected, coming in at 54.9 versus 52.5 and 52.7.

Suggestion